drugset / Trial / NCT00896571

Transdermal Contraceptive Patch - Endometrial Effects Study

NCT00896571

Phase 2 Completed 92 enrolled Bayer
Non-randomizedSingle-groupOpen-labelPrevention

Summary

The aim of the present study is to investigate the effects of the transdermal patch on the endometrium in healthy women who require contraception.

Timeline

Start
2009-07
Primary completion
2011-05
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Gestodene Small molecule 2.1 mg Other
Subject ethinyl estradiol Small molecule 0.55 mg Other

Indications

No indication recorded.